Document is current
Any future updates will be listed below
-
Authors
Mishra, Sneha
Cosentino, Claudia
Tamta, Ankit Kumar
Khan, Danish
Srinivasan, Shalini
Ravi, Venkatraman
Abbotto, Elena https://orcid.org/0000-0001-7161-6353
Arathi, Bangalore Prabhashankar
Kumar, Shweta
Jain, Aditi
Ramaian, Anand S.
Kizkekra, Shruti M.
Rajagopal, Raksha
Rao, Swathi
Krishna, Swati
Asirvatham-Jeyaraj, Ninitha
Haggerty, Elizabeth R.
Silberman, Dafne M.
Kurland, Irwin J.
Veeranna, Ravindra P.
Jayavelu, Tamilselvan
Bruzzone, Santina
Mostoslavsky, Raul https://orcid.org/0000-0002-7740-5212
Sundaresan, Nagalingam R.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R33ES025638)
U.S. Department of Health & Human Services | National Institutes of Health (R01GM128448)
U.S. Department of Health & Human Services | National Institutes of Health
- License Information
-
More Information
Article History
Received: 1 June 2020
Accepted: 24 August 2022
First Online: 15 September 2022
Competing interests
: R.M. has a financial interest in Galilei Biosciences, a company developing activators of the mammalian SIRT6 protein. R.M.’s interests were reviewed and are managed by MGH and MGB Healthcare in accordance with their conflict-of-interest policies. The other authors declare no competing interests.
